The Middleby Corporation MIDD
Set alert
124.17 USD +0.70 +0.57%
As of Nov 3, 10:52 AM ET
121.53 Day range 124.06
89.16 52-week range 148.55
- YTD
- +3.81%
- 1 year
- +26.09%
- Open
- 123.95
- Prev close
- 123.47
- Mkt cap
- 5.61B
- Vol
- 45.21K
- Avg vol
- 572.77K
- EPS
- -5.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 121.53
- High
- 124.06
- Forward P/E
- 15.87
- Beta
- 1.31
- Short ratio
- 2.65
- Inst. own
- 107.87%
- Dividend
- 0.00
- Ex-div date
- Jun 1, 2004
- Earnings
- Nov 5, 2026
- 50-d avg
- 110.04
- 200-d avg
- 120.21
- 1y target
- 154.78
Analyst view
Consensus: buy
Buy
Price target (mean) 154.78 +24.6% upside
Now 124.17
- Target (low)
- 145.00
- Target (mean)
- 154.78
- Target (high)
- 169.00
Ratings (0m) 11 9 buy · 2 hold · 0 sell
- Strong buy2
- Buy7
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.75 | 1.69 – 1.80 | 2.37 | -26.4% | 634.03M | -35.4% | 10 |
| Next quarter | 1.79 | 1.74 – 1.86 | 2.42 | -26.0% | 630.96M | -27.2% | 10 |
| Current year | 6.82 | 6.70 – 6.94 | 9.27 | -26.4% | 2.51B | -21.6% | 11 |
| Next year | 7.78 | 7.41 – 8.16 | 6.82 | +14.0% | 2.61B | +3.9% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 8, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 15, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 1, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 13, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 12, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 12, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 20, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 13, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Jefferies | Maintained | Buy | Buy |
| Jun 17, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jun 15, 2026 | Jefferies | Maintained | Buy | Buy |
| May 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 10, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Feb 27, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 24, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 10, 2025 | Jefferies | Upgrade | Hold | Buy |
| Dec 5, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 11, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 7, 2025 | JP Morgan | Upgrade | Underweight | Neutral |
| Oct 20, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 14, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Sep 4, 2025 | Wolfe Research | Initiated | — | Outperform |
| Sep 2, 2025 | Canaccord Genuity | Maintained | Buy | Buy |